SIGLEC9 blocking peptide product blog
Tags: Blocking Peptide; SIGLEC9; SIGLEC9 blocking peptide;
The SIGLEC9 siglec9 (Catalog #MBS9221582) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The SIGLEC9 siglec9 product has the following accession number(s) (GI #25009270) (NCBI Accession #Q9Y336.2) (Uniprot Accession #Q9Y336). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- or alpha-2,6-linked sialic acid. The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.
Cellular Location: Membrane; Single-pass type I membrane protein. Tissue Location: Expressed by peripheral blood leukocytes (neutrophils and monocytes but not eosinophils). Found in liver, fetal liver, bone marrow, placenta, spleen and in lower levels in skeletal muscle, fetal brain, stomach, lung, thymus, prostate, brain, mammary, adrenal gland, colon, trachea, cerebellum, testis, small intestine and spinal cordon. Blood, Bone, Brain, Lung, Pancreas, Placenta, Spleen tissues are correlated with this protein. Cell Transformation, Neoplastic, Colorectal Neoplasms, Gastrointestinal Diseases, Hematologic Diseases, Inflammation, Lung Neoplasms, Necrosis, Nervous System Diseases are some of the diseases may be linked to SIGLEC9 Antibody (C-term) Blocking Peptide. The following patways have been known to be associated with this gene.